biology - Page 14
Stories from biology come first, newest first, then stories from connected topics (genomics, AI for science, AI Science & Health, drug discovery, Biotech, Hub: Tech for Good), each labelled with where it comes from. This view is not indexed by search engines.
Latest
Google DeepMind Gives Up to 200 European Researchers Access to Its Frontier Models, Plus $3M in Compute Credits
Google DeepMind and Google Cloud will give up to 200 European researchers frontier-model access and $3M in compute credits via the EU's RAISE scheme.
Generate Biomedicines and Zealand Pharma Team Up to Design Obesity Protein Drugs With AI
Zealand Pharma will pay Generate Biomedicines $30M upfront to design AI-engineered protein drugs for obesity, with milestones worth nearly $1.2 billion.
Albert Raises $55 Million Series B Led by TCV to Bring AI Into Chemistry Labs
Albert, which makes AI software for chemistry labs, raised a $55 million Series B led by TCV. Its 45x accuracy claim for its model is its own.
Seqera Launches Nextflow Frontier, an AI System That Runs Thousands of Biology Experiments
Seqera has launched Nextflow Frontier, an AI system that runs thousands of biology experiments. Its benchmark results are Seqera's own claims.
AlphaProof Nexus Solved 9 of 353 Erdős Problems, DeepMind Says
DeepMind's AlphaProof Nexus is in Science. Its authors report 9 of 353 Erdős problems and 44 of 492 OEIS conjectures proved. What that means, and the limits.
White House Says Eleven Companies Pledged $2.4 Billion in AI Tools and Compute to the Genesis Mission
The White House says eleven companies pledged $2.4 billion in AI tools and compute credits to the Genesis Mission Consortium, led by Nvidia ($1bn), AMD ($500m) and OpenAI ($200m). Who pledged what, what the companies themselves say, and why a pledge is not spend.
Firmus Pulls Its ASX IPO as Isomorphic Labs Eyes a $40bn Valuation
Three AI business items from 8–9 October 2026: Nvidia-backed Firmus withdraws its ASX listing and turns to private money; Bloomberg reports Isomorphic Labs is in early funding talks at a valuation of at least $40 billion; and StepFun's Step 5 Preview model is now listed on OpenRouter and Vercel's AI Gateway. What is confirmed, and what is only reported.
AI in Medicine: Google’s AMIE in The Lancet, Chai and GSK, and an FDA-Cleared Autism Assessment Aid
Three AI-in-medicine items from 8–9 October 2026: a peer-reviewed Lancet feasibility study of Google's AMIE chatbot in real primary care, a company-announced collaboration between Chai Discovery and GSK on AI-designed proteins, and FDA clearance for Argus Cognitive's Neurora, an aid for clinicians that is not a stand-alone diagnostic tool. What each shows, and its limits.
Two Open Models From 8 October: a Fast Coding Agent and a Gene Finder
JetBrains has released Mellum2.1, a small open model for coding agents, and Hugging Face has released Carbon-A, a 1.2B-parameter model that predicts protein-coding regions in DNA, plus a database of 566 million predicted loci. What each does, and which numbers are the developers' own.
You Can Now Sequence the Human Genome on a Mac Mini
In October 2024, Apple launched the new Mac Mini M4 — a $599 desktop that fits in the palm of your hand. In the same breath, they...
Latest on TSN
Explore the TSN Atlas: Every topic we cover, mapped. Click a bubble to dive in.
